BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/20/2022 10:47:59 AM | Browse: 287 | Download: 543
Publication Name World Journal of Stem Cells
Manuscript ID 67752
Country China
Received
2021-05-05 09:18
Peer-Review Started
2021-05-05 09:21
To Make the First Decision
Return for Revision
2021-06-23 14:53
Revised
2021-07-20 12:10
Second Decision
2021-12-24 04:48
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-12-25 20:00
Articles in Press
2021-12-25 20:00
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2022-01-06 08:33
Publish the Manuscript Online
2022-01-20 10:47
ISSN 1948-0210 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Cell Biology
Manuscript Type Basic Study
Article Title Therapeutic effects of menstrual blood-derived endometrial stem cells on mouse models of streptozotocin-induced type 1 diabetes
Manuscript Source Invited Manuscript
All Author List Yu-Liang Sun, Ling-Rui Shang, Rui-Hong Liu, Xin-Yi Li, Sheng-Hui Zhang, Ya-Kun Ren, Kang Fu, Hong-Bin Cheng, Badrul Hisham Yahaya, Yan-Li Liu and Jun-Tang Lin
ORCID
Author(s) ORCID Number
Yu-Liang Sun http://orcid.org/0000-0002-6338-0077
Ling-Rui Shang http://orcid.org/0000-0001-5007-0646
Rui-Hong Liu http://orcid.org/0000-0003-2449-161X
Xin-Yi Li http://orcid.org/0000-0001-7578-3183
Sheng-Hui Zhang http://orcid.org/0000-0002-2760-6550
Ya-Kun Ren http://orcid.org/0000-0002-7961-8430
Kang Fu http://orcid.org/0000-0002-9228-3161
Hong-Bin Cheng http://orcid.org/0000-0001-8963-8702
Badrul Hisham Yahaya http://orcid.org/0000-0002-3295-9676
Yan-Li Liu http://orcid.org/0000-0003-0886-8907
Jun-Tang Lin http://orcid.org/0000-0001-9300-1771
Funding Agency and Grant Number
Funding Agency Grant Number
Henan Province Foundation of China 202300410307
Henan Province Foundation of China 212102310611
Xinxiang City Foundation of China GG2020009
Corresponding Author Jun-Tang Lin, PhD, Professor, Stem Cell and Biotherapy Technology Research Center, Xinxiang Medical University, East of JinSui Road, Xinxiang 453000, Henan Province, China. linjt@xxmu.edu.cn
Key Words Type 1 diabetes; Menstrual blood-derived endometrial stem cell; Umbilical cord mesenchymal stem cells; Improvement; Complication
Core Tip Mesenchymal stem cell (MSC)-based therapies have resulted in promising improvements for patients with type 1 diabetes (T1D). Menstrual blood-derived endometrial stem cells (MenSC) transplantation has therapeutic effects equal to those of umbilical cord-derived MSC, which can significantly improve the symptoms of streptozotocin-induced T1D mice and exert protective effects on their main organs; MSC-induced angiogenesis, antiapoptotic effects and immunomodulation contribute to these protective effects. The results of this study showed that MenSC are expected to become a promising alternative for clinical diabetes treatment due to their advantages, including their regular and noninvasive collection protocol, abundant availability, and superior proliferative capacity.
Publish Date 2022-01-20 10:47
Citation Sun YL, Shang LR, Liu RH, Li XY, Zhang SH, Ren YK, Fu K, Cheng HB, Yahaya BH, Liu YL, Lin JT. Therapeutic effects of menstrual blood-derived endometrial stem cells on mouse models of streptozotocin-induced type 1 diabetes. World J Stem Cells 2022; 14(1): 104-116
URL https://www.wjgnet.com/1948-0210/full/v14/i1/104.htm
DOI https://dx.doi.org/10.4252/wjsc.v14.i1.104
Full Article (PDF) WJSC-14-104.pdf
Full Article (Word) WJSC-14-104.docx
Manuscript File 67752_Auto_Edited.docx
Answering Reviewers 67752-Answering reviewers.pdf
Audio Core Tip 67752-Audio core tip.m4a
Biostatistics Review Certificate 67752-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 67752-Conflict-of-interest statement.pdf
Copyright License Agreement 67752-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 67752-Grant application form(s).pdf
Institutional Animal Care and Use Committee Approval Form or Document 67752-Institutional animal care and use committee statement.pdf
Non-Native Speakers of English Editing Certificate 67752-Language certificate.pdf
Peer-review Report 67752-Peer-review(s).pdf
Scientific Misconduct Check 67752-Bing-Fan JR-2.png
Scientific Editor Work List 67752-Scientific editor work list.pdf